Albertsons Raises Dividend 13% to $0.17 and Joins National Opioid Settlement
Albertsons Companies’ Board declared a 13% increase in its quarterly common stock dividend to $0.17 per share, raising the annualized rate to $0.68 with payment on May 8. The company also announced its participation in a national opioid settlement framework to address ongoing litigation risks.
1. Board Approves 13% Dividend Increase
The Board declared a quarterly cash dividend of $0.17 per share for the first quarter of fiscal 2026, representing an annualized rate of $0.68 per share. This marks a compound annual growth rate of 10% since the June 2020 IPO and underscores the company’s strong free cash flow generation and balanced capital allocation.
2. Participation in National Opioid Settlement Framework
Albertsons announced its participation in a comprehensive national opioid settlement framework designed to resolve multidistrict litigation and limit future claims. Joining this framework is expected to reduce legal uncertainty and cap potential financial exposure related to opioid lawsuits.